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Abstract:  The  CombiMatrix  antibody  microarray  is  a  versatile,  sensitive  detection 
platform based on the generation and transduction of electrochemical signals following 
antigen binding to surface antibodies. The sensor chip described herein is comprised of 
microelectrodes coupled to an adjacent bio-friendly matrix coated with antibodies to the 
biological  pathogens  Yersinia  pestis  and  Bacillus  anthracis,  and  the  bacterial  toxin 
staphylococcal enterotoxin B (SEB). Using this system, we were able to detect SEB and 
inactivated Y. pestis individually as well as in two-plex assays at concentrations as low as  
5 pg/mL  and 10
6 CFU/mL, respectively. We also introduce super avidin-biotin system 
(SABS)  as  a  viable  and  effective  means  to  enhance  assay  signal  responses  and  lower 
detection  limits.  Together  these  technologies  represent  substantial  advances  in  
point-of-care and point-of-use detection applications. 
Keywords:  CombiMatrix;  microarray;  biosensor;  electrochemical  detection;  super  
avidin-biotin system (SABS); immunoassay; pathogen detection 
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1. Introduction 
Microarrays  have  risen  to  the  forefront  of  preferred  analytical  technologies  for  a  variety  of 
molecular applications including genetic studies, pathogen detection, and environmental sampling [1-6]. 
The key features of microarray technology are the exploitation of biological sensing elements for 
antigen recognition and the ability to screen those antigens against a vast array of probes. Although 
most  arrays  have  traditionally  relied  on  DNA-based  sensing  elements,  advances  in  substrate  and 
immobilization technology have made protein microarrays appealing for many sensing applications [7-11]. 
By  combining  the  features  of  a  protein-based  antibody  array  into  a  single  chip-based  entity, 
CombiMatrix  has  created  a  powerful  detection  platform  that  lends  itself  well  to  point-of-use  and  
point-of-care applications. 
CombiMatrix  semiconductor  chips  are  comprised  of  12,544  individually  addressable 
microelectrodes  that  utilize  complementary  metal  oxide  semiconductor  (CMOS)  technology  to 
measure  the  transduction  of  electrochemical  signals  resulting  from  an  enzyme-enhanced 
electrochemical reaction following antigen binding to the appropriate recognition element. These chips 
are flexible in design and can be patterned with nucleic acid or protein recognition elements specific 
for a variety of antigens. CombiMatrix oligonucleotide arrays have been utilized in genotyping and 
gene expression assays [12], and antibody chips have been shown to successfully recognize a variety 
of analytes including saxitoxin and bacterial spores [13], the plant lectin ricin, M13 phage, and α-1 
acid glycoprotein [14]. 
Although many detection platforms utilize fluorescence as a readout method, use of an enzymatic 
amplification step may improve detection due to the catalytic turnover of substrate. Amperometric 
electrochemicial  detection  as  performed  in  the  CombiMatrix  ElectraSense®  reader  relies  on  the 
generation of electrons following the oxidation of substrate by horseradish peroxidase (HRP). This 
detection method has been shown to be both sensitive and specific in a variety of applications [12-15]. 
Amperometric-based sensors offer several advantages over other detection platforms including their 
cost-effectiveness, design flexibility, potential for miniaturization, and sensitivity [16]. 
Herein we describe the first use of the CombiMatrix antibody microarray designed towards the 
biological  pathogens  Yersinia  pestis,  Bacillus  anthracis,  and  the  bacterial  toxin  staphylococcal 
enterotoxin  B  (SEB).  Using  this  platform,  we  were  able  to  detect  SEB  and  inactivated  Y.  pestis 
individually as well as in two-plex assays at concentrations as low as 5 pg/mL and 10
6 colony-forming 
units  (CFU)/mL,  respectively.  In  addition,  we  introduce  super  avidin-biotin  system  (SABS)  as  a 
method to enhance electrochemical signal generation. SABS works by using high-affinity streptavidin 
(SA)-biotin binding to create layers of poly-HRP, resulting in the creation of an enzyme scaffold that 
amplifies signal intensity. This technique has widespread applicability and can be used in instances 
where it is necessary to boost the lower detection limit of an enzyme assay. 
2. Results and Discussion 
The CombiMatrix ElectraSense® microarray is mounted on a ceramic base the size of a microscope 
slide. Because the array has a platinum surface, it is resistant to most corrosive chemicals and supports 
the electrochemistries required for building customizable antibody or DNA microarrays as well as 
those  for  detecting  macromolecular  binding  on  the  array.  Following  completion  of  the  assay  wet Sensors 2010, 10                                      
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chemistry  steps,  microarrays  are  inserted  into  an  ElectraSense
®  reader  for  amperometric  signal 
measurement at individual electrodes. For the purposes of our studies, we used CombiMatrix 4X2K 
chips that contained four identical sub-arrays of surface-immobilized antibodies designed to recognize 
the bacterial toxin SEB and pathogens, B. anthracis and Y. pestis. These capture antibodies function to 
bind target antigen on the chip surface. Following binding of antigen to the array, electrochemical 
detection  is  accomplished  via  the  sequential  addition  of  biotinylated  detection  antibodies,  
streptavidin-conjugated poly-horseradish peroxidase (PHRP-SA), and finally hydrogen peroxide and 
tetramethylbenzidine  (TMB)  substrate.  PHRP-SA  is  a  multimeric  reagent  that  acts  to  amplify  the 
detection signal by providing multiple HRP molecules for the oxidation of TMB substrate. The four 
sub-arrays  contained antibodies  for the three target  antigens  and were used in  conjunction  with a  
four-chamber hybridization cap that allowed for four independent assays on a single microarray. Each 
sub-array contained 20 antibody blocks, 5 for each immobilized antibody (15 total) and 5 for no-Ab 
negative controls. Each of the 5 blocks for a specific target contained 15 antibody-electrode pairs  
(75  total  per  sub-array).  Using  the  CombiMatrix  ElectroSense®  reader,  all  four  sub-arrays  were 
measured simultaneously. An image of the CombiMatrix array and setup can be seen in Figure 1. For 
the  purpose  of  our  study,  signals  from  an  antigen-specific  array  must  meet  three  criteria  to  be 
considered positive: (1.) a signal-to-noise (S/N) ratio of greater than 3; (2.) a signal-to-background 
(S/B) ratio of greater than 2; and (3.) a signal to “zero”(no antigen) (S/Z) ratio of greater than 2.  
Figure 1. CombiMatrix antibody microarray (A) Arrays are subdivided into four identical 
sub-arrays divided into 20 discrete antibody blocks each; (B) Hybridization clamp that 
holds the chip and hybridization cap covering the microarray; (C) Fully assembled clamp, 
cap, and chip. 
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We  first  characterized  the  detection  limit  of  the  chips  for  SEB  by  incubating  arrays  with  1 -100 
pg/mL SEB and interrogating with biotinylated anti-SEB. These experiments were designed to contain 
several  controls  for  non -specific  binding  including  a  buffer  control  (no  antigen  p resent),  surface 
negative control loci (no antibody present on surface), and non-specific antibody arrays. In these initial 
assays, SEB could be detected as low as 10 pg/mL (S/N  = 15.03; S/B = 4.37; S/Z = 4.35) (Figure 2). 
Coefficients of variation (CVs) for SEB-specific loci generally ranged from 5 to 20%. Although CVs Sensors 2010, 10                                      
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from  microelectrodes  directed  against  other  targets  (or  no  targets)  were  generally  higher,  the 
electrochemical signals from these latter loci were lower. Over the range of SEB concentrations tested, 
we did not observe the presence of non-specific positive signals using the criteria detailed above.  
Figure 2.  Electrochemical detection (ECD) assay for SEB.  Antibody microarrays were 
incubated with 0 pg/mL, 1 pg/mL, 10 pg/mL, or 100 pg/mL SEB. Anti-B. anthracis, anti-Y. 
pestis, and anti-SEB refer to the antibodies immobilized on the chip surface. (A) Mean 
signals and SD; (B) Image of microarray. 
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Having established the baseline limit of detection for SEB, we sought to improve assay sensitivity 
using  a  super  avidin -biotin  system  (SABS). This  system  relies  on  creating  layers  of  PHRP -SA 
scaffolding  to  increase  signal  generation  ( Figure  3).  SABS  can  be  accomplished  using  either 
biotinylated anti-SA or biotinylated anti-HRP antibodies to serve as poly -HRP-SA linkers. In direct 
comparisons,  we  found  the  former  performed  better  than  the  latter  in  terms  of  specificity  and 
amplitude of signal enhancement (data not shown) and was employed in subsequent experiments.  
Figure 3. Schematic overview of SABS signal enhancement. 
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To investigate the ability of SABS to enhance assay sensitivity for SEB, chips were incubated with 
0, 0.5, 5, or 50 pg/mL SEB and experiments were performed as previously described up through the 
ElectraSense®  measurement.  We  then  added  biotinylated  anti-SA  followed  by  PHRP-SA,  TMB 
substrate, and measured again (Figure 4). If measured prior to incubation with biotinylated anti-SA 
(measurement #1), a noticeable signal from SEB was present at 5 pg/mL, although this increase was 
not deemed positive based on our pre-defined criteria (S/N = 4.39; S/B = 1.62; S/Z = 2.33). Signals 
from all other non-specific spots were not significantly different from  background or noise levels 
based on the same criteria. Following SABS treatment (measurement #2), the detection limit for SEB 
improved to 5 pg/mL (S/N = 9.98; S/B = 5.07; S/Z = 2.63), suggesting that the SABS treatment was 
effective in  enhancing signal  generation, despite a general  trend of higher standard deviations for 
SABS-treated samples. The increased CV values in these experiments were not surprising since any 
additional manipulations following the initial measurement have the potential for increasing overall 
variability at both target-specific and non-specific loci. Also, although we observed a small increase in 
signals non-specific loci following SABS treatment, these changes did not confound analysis, as they 
were much smaller than the SEB-specific signal amplification and did not generate any false positives 
based on the S/N, S/B, and S/Z criteria. 
Figure 4. SABS assay for SEB. Chips were incubated with 0 pg/mL, 0.5 pg/mL, and 5 
pg/mL. Anti-B. anthracis, anti-Y. pestis, and anti-SEB refer to the antibodies immobilized 
on the chip surface. Mean signals and SD are indicated. 
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One aspect of the SABS experiments that warranted investigation was the possibility the first (pre-
SABS)  ECD  measurement  compromised  the  ability  of  SABS  to  enhance  signal  generation.  We 
reasoned that if the TMB precipitates onto the chip surface during the first reading, it may foul the 
surface  and  prevent  subsequent  binding  of  biotinylated  anti-SA  to  the  PHRP-SA  molecules. 
Comparison  of  a  two-measurement  protocol  (as  done  in  the  previous  experiment)  with  a  single  
post-SABS measurement revealed that while the single measurement protocol produced higher signals 
overall, the patterns were not altered (data not shown). Sensors 2010, 10                                      
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We next investigated the detection capabilities of the antibody microarray for inactivated Y. pestis. 
As can be seen in Figure 5, using a dilution series from 10
5-10
7 CFU/mL, we were able to detect Y. 
pestis as low as 10
6 CFU/mL prior to SABS treatment (S/N = 6.06; S/B = 3.67; S/Z = 5.05). There was 
no improvement in the detection limit following SABS treatment; however, there was an improvement 
in most signal ratios (S/N = 14.81; S/B = 8.37; S/Z = 4.24). The increased background post-SABS 
inhibited detection of a positive signal at 10
5 CFU/mL (S/N = 4.36; S/B=2.42; S/Z = 1.64). Although 
non-specific signal  amplifications were observed for SEB and  B. anthracis-specific loci following 
SABS treatment, these increases did not meet our criteria for positive signals. In contrast to the post-
SABS results from SEB assays, the overall variability for target-specific and non-specific loci did not 
increase  significantly  after  SABS  amplification.  Curiously,  the  signal  from  the  most  concentrated 
sample of Y. pestis (10
7 CFU/mL) was lower than anticipated following SABS treatment. This has 
been periodically observed for SEB samples as well (data not shown) and may reflect a fouling of the chip 
surface by precipitated TMB that acts to inhibit diffusion of electroactive species to the array electrodes.  
Figure 5. SABS assay for Y. pestis. Chips were incubated with 0, 10
5, 10
6, or 10
7 CFU/mL 
inactivated Y. pestis, followed by interrogation with  biotinylated anti-Y. pestis.  Anti-B. 
anthracis, anti-Y. pestis, and anti-SEB refer to  the antibodies immobilized on the chip 
surface. Mean signals and SD are indicated. 
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Since all previous experiments were performed in buffer, we sought to emulate a more complex 
physiological  environment  by diluting antigens  in  the presence of 50% serum.  In agreement with 
experiments  performed  in  buffer,  we  observed  a  dose-response  to  spiked  Y.  pestis  and  positive 
detection  at  10
6  CFU/mL  following  SABS  treatment  (S/N  =  14.49;  S/B  =  10.18;  S/Z  =  3.28) 
(Figure 6), although absolute signal intensity was noticeably blunted in the presence of 50% serum 
when compared to buffer. This was an improvement from the pre-SABS LOD of 10
7 CFU/mL in 50% 
serum (S/N = 11.82; S/B = 10.11; S/Z = 9.05). Similar to previous SABS experiments, we observed 
some increase in  signals  from  of non-specific loci,  but  none of the anti-B. anthracis  or anti-SEB Sensors 2010, 10                                      
 
 
3357 
signals were positive based on our criteria; variability of these signals were not greatly affected by the 
presence of serum. In contrast, analogous experiments with SEB were found to be inconclusive, as 
signal levels were inconsistent and did not indicate any reproducible pattern (data not shown). Previous 
biosensor experiments for SEB detection in spiked serum samples have shown similar results [17]. The 
authors postulated that the presence of endogenous antibodies directed against SEB may have interfered with 
binding.  
Figure 6. Y. pestis assay in 50% serum. Chips were incubated with 0, 10
5, 10
6, or 10
7 
CFU/mL  inactivated  Y.  pestis  diluted  in  50%  human  serum.  Anti-B.  anthracis,  anti-Y. 
pestis, and anti-SEB refer to the antibodies immobilized on the chip surface. Mean signals 
and SD are indicated. 
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An important feature of detection systems is the ability to run multiplexed reactions for several 
targets  simultaneously.  CombiMatrix  microarrays  satisfy  this  requirement  and  are  designed  to 
recognize multiple targets tailored to the specific needs of the assay. For the purposes of this study, we 
chose to examine Y. pestis and SEB antigens in a multiplex format. First we ensured the absence of 
cross-reactivity  or  interference  between  anti-Y.  pestis  and  anti-SEB  antibodies.  This  was  done  by 
adding anti-Y. pestis antibodies to SEB assays and vice versa (data not shown). We next investigated 
the ability to perform two-plex assays by adding both Y. pestis and SEB to the same chips in reverse 
concentration patterns and interrogating with a mixture of anti-Y. pestis and anti-SEB antibodies. As 
can be seen in Figure 7, both Y. pestis and SEB can be detected on the same chip at 10
6 CFU/mL  
(S/N = 3.80; S/B = 2.21; S/Z = 6.25) and 50 pg/mL (S/N = 3.74; S/B = 2.05; S/Z = 4.17), respectively. 
These results  are in  agreement with  those previously observed for  individual assays.  Interestingly 
however, signal variability increased significantly at the highest Y. pestis concentration, but only on the 
Y. pestis-specific loci (~10% CV to ~35% CV); the cause for this effect is unknown. When exposed to 
SABS amplification, Y. pestis and SEB were detectable at 10
6 CFU/mL (S/N = 9.54; S/B = 5.31;  
S/Z = 10.07) and 5 pg/mL (S/N = 7.77; S/B = 3.54; S/Z = 3.45), respectively. Again we observed a Sensors 2010, 10                                      
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similar  increase  in  Y.  pestis  signal  variability  at  the  highest  concentration  used.  The  lack  of  an 
observable decline in signal between 10 pg/mL and 5 pg/mL SEB is likely due to detection limitation 
rather  than  cross-reactivity,  as  supported  by  results  in  Figure  2  which  shows  there  is  not  a  large 
difference in signal between 1 pg/mL and 10 pg/mL SEB. Combined with the lack of “positive” results 
on  the  non-specific  loci  under  these  conditions,  these  results  clearly  demonstrate  the  multiplex 
capabilities of the CombiMatrix antibody microarray and the signal-enhancing properties of SABS. 
Figure 7. Two-plex assay for SEB and Y. pestis. Chips were incubated with 0, 10
5, 10
6, or 
10
7 CFU/mL Y. pestis and 0, 5, 10, or 50 pg/mL SEB. Anti-B. anthracis, anti-Y. pestis, and 
anti-SEB refer to the antibodies immobilized on the chip surface. Mean signals and SD are 
indicated. Note: breaks in SEB line serve as a reminder that concentrations for all samples 
are not continuous and that lines are only used to illustrate trends.  
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The limits  of detection (lowest  positive concentration) for SEB attained with the CombiMatrix 
antibody microarray compare favorably with other commercial detection systems and laboratory-based 
assays.  Enzyme-linked  immunosorbent  assays  (ELISA)  have  been  shown  to  detect  as  low  as  
0.5 ng/mL SEB [18]. Similarly, surface plasmon resonance (SPR) studies have recognized SEB as low 
as  0.5  ng/mL  using  a  sandwich  assay  format  and  5  ng/mL  with  direct  detection  [19].  While  the 
Luminex flow cytometer (Luminex Corp., Austin, TX) is capable of detecting SEB at 50–100 pg/mL [20], 
it is still above the detection limits of the CombiMatrix system. In comparison to portable biosensors, 
the  CombiMatrix  system  outperforms  the  fluorescence-based  RAPTOR  fiber  optic  biosensor 
(Research International, Seattle, WA) and the NRL Array Biosensor which are capable of detecting 
SEB at  0.5 ng/mL [21] and 0.1 ng/mL  [22,23], respectively.  In regards  to  Y. pestis  detection, as 
performed, the CombiMatrix system was not as competitive as some other antibody-based assays. Y. 
pestis  could  be  detected  as  low  as  10
4  CFU/mL  using  an  up-converting  phosphor  technology  
(UPT)-based  lateral-flow  immunoassay  [24],  and  a  Luminex-based  assay  using  as  sandwich-assay 
format was able to detect aerosolized Y. pestis at 6  10
3 CFU/mL [25]. 
\\ 
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Although the CombiMatrix antibody microarray system fares well overall in comparison with other 
detection  systems,  future  assay  optimization  may  enhance  performance.  One  such  potential 
improvement would be reducing assay time. Once the antibodies are patterned on the microarray, a 
typical assay takes about 3.5 h (5 h with SABS). Although most of these steps are not labor-intensive, 
if incubation steps could be shortened, the assay would become much more appealing to users desiring 
a rapid detection system. Another promising aspect for optimization is the employment of different 
detection antibodies. Replacement of the polyclonal antibodies used in these assays with monoclonal 
antibodies  of  higher  sensitivity  and  selectivity  may  improve  specific  target  detection  and  reduce 
background levels. In support of this possibility are previous findings that demonstrate the ability to 
enhance detection limits for SEB by using different SEB capture antibodies [22].  
3. Experimental 
3.1. Materials 
CombiMatrix 4X2K antibody microarrays were supplied by CombiMatrix Corp [26]. These chips 
contained 4 identical sub-arrays, each of which contained 20 spots divided into 4 rows (from top to 
bottom: no antibody, anti-B. anthracis, anti-SEB, and anti-Y. pestis antibodies, with 5 replicate spots 
for  each  row).  Rabbit  polyclonal  anti-SEB  and  anti-Y.  pestis  antibodies  were  obtained  from  the 
Department  of  Defense  Critical  Reagents  Program  (CRP)  (Edgewood,  MD).  Biotinylated  tracer 
antibodies were labeled using EZ link Sulfo-NHS-LC-biotin (Pierce, Rockford, IL). Biotinylated goat 
anti-streptavidin was purchased from Vector Laboratories Inc. (Burlingame, CA). Biotinylated rabbit 
anti-HRP was purchased from Jackson Immunoresearch (West Grove, PA). Poly-HRP40-streptavidin 
was obtained from Fitzgerald Industries International, Inc. (Concord, MA). SEB toxin was procured 
from Toxin Technologies (Sarasota, FL). Human sera were archived samples previously taken from 
healthy volunteers with informed consent. Inactivated Y. pestis was obtained from the Department of 
Defense Critical Reagents Program (CRP) (Edgewood, MD) and certified inactive prior to shipping. 
Technical grade casein was purchased from Sigma (St. Louis, MO). ElectraSense® TMB substrate and 
TMB rinse solutions were provided by CombiMatrix Corp. (Mukilteo, WA)  
3.2. Methods 
ElectroSense® assay–Arrays were hydrated in phosphate buffered saline/0.1% Tween-20 (PBST) 
for  20  min.  Chips  were  then  rinsed  with  phosphate  buffered  saline/0.3%  casein/0.1%  Tween-20 
(PBSCT) and blocked with fresh PBSCT for 20 min. Following another rinse with PBSCT, SEB or 
inactivated Y. pestis antigen (diluted in PBSCT or 50% serum) was then applied for 1 hour. Chips were 
then rinsed 4 times with PBSCT then incubated with the appropriate antibody for 1 hour. Biotinylated 
SEB antibody was used at 2 μg/mL while anti-Y. pestis antibody was used at 4 μg/mL. Chips were 
rinsed 4 times with PBSCT then incubated with poly-HRP40-streptavidin (PHRP40-SA) for 30 min. 
Chips  were  then  rinsed  5  times  with  PBSCT,  once  with  PBS,  then  twice  with  TMB  rinse.  An 
amperometric electrochemical measurement was then taken following the addition of TMB substrate. 
All incubations were performed at room temperature on a rotating wheel unless otherwise indicated. Sensors 2010, 10                                      
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Super avidin-biotin system (SABS)–Following the first measurement as described above, chips were 
rinsed 4 times with PBSCT. Biotinylated goat anti-streptavidin was added at 10 μg/mL for 1 hour. 
Chips were then treated as above starting with 4 times PBSCT rinses and incubation with PHRP40-SA 
for 30 min.  
Statistical analysis–For our purposes, three criteria were used to determine whether a signal was 
statistically significant (i.e., positive): (1.) a signal-to-noise (S/N) ratio of greater than 3; (2.) a signal-
to-background (S/B) ratio of greater than 2; and (3.) a signal to “zero”(i.e., no antigen) (S/Z) ratio of 
greater than 2. The S/N ratio was defined as the [(mean antibody-specific array x signal-mean buffer 
array x signal) / SD of buffer array x signal] and is commonly used to assess assay performance. The 
S/N ratio takes into account the standard deviation of the measurements; a S/N ratio of ≥3 was chosen 
to provide a 99% confidence interval. The S/B ratio was [mean antibody-specific array x signal / mean 
buffer array x signal]. This ratio controls for potential intra-sub-array variability, as both the no-Ab and 
antibody-specific signals were from the same sub-array. The S/Z ratio is described as [mean antibody-
specific array x signal / mean antibody-specific array buffer signal], where the denominator is the mean 
signal from the buffer condition array for that specific antibody. The S/Z ratio is important to compare 
different sub-arrays on the same chip because the buffer (no antigen) condition was performed on a 
different sub-array then the antigen dose conditions. We empirically determined that the combination 
of these threshold conditions yielded the highest level of sensitivity while minimizing the potential for 
false positives (data not shown), thus all three criteria must be met for a signal to be considered positive. 
4. Conclusions 
Herein  we  describe  application  of  the  CombiMatrix  antibody  microarray  system  designed  for 
detection of the bacterial pathogens B. anthracis, Y. pestis, and SEB. Using a protocol involving the 
use of polymeric HRP-SA conjugate, we were able to detect SEB and Y. pestis as low as 5 pg/mL and 
10
6 CFU/mL, respectively, in assays incorporating a SABS amplification step. We demonstrate the 
ability to detect these pathogens individually as well as in a two-plex assay format. In addition to its 
ease-of-use and portability, the versatility, flexibility, and sensitivity of the CombiMatrix technology 
make it an attractive solution to the detection needs of a variety of sensor-based areas including disease 
diagnosis, genetic screenings, and biological/chemical warfare (BCW) threat applications.  
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